The LipidWeb blank

Sphingolipids - Chemistry and Biochemistry
An Introduction

1.  Sphingolipid Basics

The sphingolipids comprise a wide range of complex lipids in which the defining component is a long-chain or sphingoid base, which is usually linked to a fatty acid via an amide bond. J.L.W. Thudichum first coined the root term “sphingo-” in 1884 because the enigmatic nature of the molecules reminded him of the riddle of the sphinx. The term “sphingolipide” was introduced by Herbert Carter and colleagues in 1947. While they are perhaps less enigmatic than they once were, sphingolipids are extremely versatile molecules that continue to fascinate as new knowledge is gained of their functions in healthy and diseased animal and plant tissues. They are found in only a few bacterial genera, but they are present in Sphingomonas and Sphingobacterium species, and many pathogenic species utilize host sphingolipids to promote infections. Novel sphingolipid structures continue to be reported, and as an example at the last count, 188 of the complex sphingolipids classified as gangliosides, with variations in the complex carbohydrate component alone, had been characterized in vertebrates.

Sphingolipid building blocks

Long-chain or sphingoid bases, of which sphingosine (illustrated) is typical, are the basic elements and are the simplest possible functional sphingolipids. They vary in chain-length and in the presence of various functional groups including double bonds of both the cis- and trans-configuration at different locations in the aliphatic chain. Ceramides, which contain sphingoid bases linked to fatty acids by amide bonds, vary appreciably in the compositions of both aliphatic components, depending on their biological origins. Long-chain bases and ceramides have important biological properties in their own right, for example in relation to intra- and inter-cellular molecular signalling, especially in animal cells, while another relatively simple sphingolipid, sphingosine-1-phosphate, is now recognized as a key factor in countless aspects of animal metabolism. The concentrations of these bioactive lipids respond rapidly to the action of specific stimuli and then regulate downstream effectors and targets.

Ceramides are the precursors of a multitude of sphingo-phospho- and sphingo-glycolipids with an immense range of functions in tissues. The properties and functions of these complex sphingolipids are quite distinct from those of the glycerophospho- and glycolipids. For example in animals, sphingomyelin has structural similarities to phosphatidylcholine, but has very different physical and biological properties, while the complex oligoglycosylceramides and gangliosides (glycosphingolipids), of which glucosylceramide is the precursor, have no true parallels among the glyceroglycolipids. There are appreciable differences in sphingolipid compositions and metabolism between animal and plant cells, both with respect to the aliphatic components and especially the polar head groups, although there are also some important similarities.

Complex sphingolipids

Complex sphingolipids are located mainly in the plasma membrane of mammalian cells where they have a structural function and also serve as adhesion sites for proteins from the extracellular tissue. The glycosphingolipids are especially important in the brain. However, sphingolipids have intracellular functions in all cellular compartments, including the nucleus. Although less is known of the role they play in plants, it has become apparent that complex sphingolipids are much more abundant in plant membranes than was once believed, and it is now recognized that they are key components of the plasma membrane and endomembrane system. A distinctive property of sphingolipids in membranes is that they spontaneously form transient nanodomains termed 'rafts', usually in conjunction with cholesterol, where specific proteins such as enzymes and receptors congregate to carry out their signalling and other functions. Thus, in addition to their direct effects on metabolism, sphingolipids affect innumerable aspects of biochemistry indirectly via their physical properties.

While it may be obvious that a well-balanced sphingolipid metabolism is important for health in animals, increasing evidence has been acquired to demonstrate that impaired sphingolipid metabolism and function are involved in the pathophysiology of many of the more common human diseases. These include diabetes, various cancers, microbial infections, Alzheimer's disease and other neurological syndromes, and diseases of the cardiovascular and respiratory systems. A number of genetic defects in sphingolipid metabolism or sphingolipidoses, especially lysosomal storage diseases, are also important in humans. Sphingolipids and their metabolism are therefore likely to prove of ever increasing interest to scientists.

2.  Some General Comments on Sphingolipid Metabolism

The biosynthesis and catabolism of sphingolipids involves a large number of intermediate metabolites, all of which have distinctive biological activities of their own. In animals, the relationships between these metabolites have been rationalized in terms of a ‘sphingomyelin, sphingolipid or ceramide cycle’.

The sphingomyelin cycle

Many different enzymes (and their isoforms) are involved, and their activities depend on a number of factors, including intracellular locations and mechanisms of activation. Each of the various compounds in these pathways has characteristic metabolic properties, and these are discussed in more detail on the web pages describing the individual sphingolipids. Thus, free sphingosine and other long-chain bases, which are the primary precursors of ceramides and thence of all the complex sphingolipids, function as mediators of many cellular events, for example by inhibiting the important enzyme protein kinase C. Ceramides are involved in cellular signalling, and especially in the regulation of apoptosis, and cell differentiation, transformation and proliferation, and most stress conditions. In contrast, sphingosine-1-phosphate and ceramide-1-phosphate promote cellular division (mitosis) as opposed to apoptosis, so that the balance between these lipids and ceramide and/or sphingosine levels in cells is critical.

Similarly, the ‘structural’ sphingolipids, such as sphingomyelin, monoglycosylceramides, oligoglycosylceramides, gangliosides and sulfatides, all have unique and characteristic biological functions, a high proportion of which are due to their physical properties and location within raft nanodomains of membranes. Most of the reactions in the sphingomyelin cycle are reversible and the relevant enzymes are located in the endoplasmic reticulum, Golgi, plasma membrane and mitochondria, but the more complex sphingolipids are catabolized in the lysosomal compartment. Sphingolipids are especially important in providing the permeability barrier in skin, where they are characterized by the presence of ultra­long fatty acyl components as well as fatty acyl groups linked to the terminal end of the N‑linked fatty acids (thereby generating a three‑chain rather than a two‑chain molecule).

Metabolic pathways that are comparable to those of the sphingomyelin cycle are believed to occur in plants, although they have not been studied as extensively as those in animals (sphingomyelin itself does not occur in plants). However, sphingolipid metabolites such as sphingosine-1-phosphate (or analogues) have been linked to programmed cell death, signal transduction, membrane stability, host-pathogen interactions and stress responses, for example.

Sphingolipid biosynthetic pathways in plants

Plants also have a unique range of complex sphingolipids in their membranes, such as ceramide phosphorylinositol and the phytoglycosphingolipids, and these are now known to constitute a higher proportion of the total lipids than had hitherto been supposed, although their functions have hardly been explored. While sphingolipids are produced by relatively few bacterial species, sulfono-analogues of long-chain bases and ceramides (capnoids) are produced by some species, but for convenience, these are discussed with the sulfonolipids

3.  Fatty acid Components of Sphingolipids

The fatty acids of sphingolipids are very different from those of glycerolipids, consisting of very-long-chain (up to C26) odd- and even-numbered saturated or monoenoic and related 2-R-hydroxy components, while even longer fatty acids (C28 to C36) occur in spermatozoa and the epidermis. The dienoic acid 15,18-tetracosadienoate (24:2(n-6)), derived from elongation of linoleic acid, is found in the ceramides and other sphingolipids of a number of different tissues, but at relatively low levels. Polyunsaturated fatty acids are only rarely present, although sphingomyelins of testes and spermatozoa are exceptions in that they contain such fatty acids, which are even longer in chain-length (up to 34 carbon atoms) and include 28:4(n-6) and 30:5(n-6). Skin ceramides also contain unusual very-long-chain fatty acids, while yeast sphingolipids are distinctive in containing mainly C26 fatty acids. In plants and yeasts, a similar range of chain-lengths occur as in animals, but 2-hydroxy acids predominate sometimes accompanied by small amounts of 2,3-dihydroxy acids; saturated fatty acids are most abundant, but monoenes are present in higher proportions in the Brassica family (including Arabidopsis) and a few other species.

Very-long-chain saturated and monoenoic fatty acids are produced from medium-chain precursors by elongases (ELOVL) in the endoplasmic reticulum of cells in mammals, and there is increasing evidence that specific isoforms are involved in the biosynthesis of certain ceramides (see our web page on long-chain bases). For example, ELOVL1 has been linked to the production of ceramides with C24 fatty acids (saturated and unsaturated), while ELOVL4 is responsible for the ultra-long-chain fatty acids in skin. Yeasts possess three elongation enzymes: Elo1p (for medium to long-chain fatty acids), Elo2p (up to C22) and Elo3p (up to C26). Hydroxylation is effected by a fatty acid 2-hydroxylase in mammals, i.e. an NAD(P)H-dependent monooxygenase, which is an integral membrane protein of the endoplasmic reticulum. It converts unesterified long-chain fatty acids to 2‑hydroxy acids in vitro and probably also in vivo. For example, experimental evidence has been obtained that is consistent with 2‑hydroxylation occurring at the fatty acid level prior to incorporation into ceramides in the brain of mice where the enzyme is expressed at high levels. A second enzyme of this kind is known to exist but has yet to be characterized, and it is possible that a proportion of the odd-chain fatty acids in brain are synthesised by peroxisomal α-oxidation of the 2‑hydroxy acids. Similarly, in skin, 2‑hydroxy and non-hydroxy fatty acids as their CoA esters are used with equal facility for ceramide biosynthesis by ceramide synthases. Mutations in the fatty acid 2-hydroxylase gene in humans lead to leukodystrophy and neurodegeneration.

Scottish thistleIn plants, it appears that 2‑hydroxyl groups are inserted into fatty acyl chains while they are linked to ceramide, as ceramide synthase does not accept hydroxy fatty acids in vitro at least. Two fatty acid 2‑hydroxylases (di-iron-oxo enzymes) have been found in Arabidopsis, with one specific for very-long-chain fatty acids and one for palmitic acid.

Although the fatty acids are only occasionally considered in terms of the biological functions of sphingolipids, their influence is considerable, especially but not only in relation to their physical properties and function of sphingolipids in membranes. For example, very-long-chain fatty acids may play a role in stabilizing highly curved membrane domains as is required during cell division. The hydrophobic nature of the fatty acyl groups (together with the long-chain bases) enables the hydrogen bonding that is essential for the formation of raft nanodomains in membranes. As a general rule, lipid bilayers containing sphingolipids with 2-hydroxy-fatty acyl or 4-hydroxy-sphingoid base moieties, tend to generate condensed and more stable gel phases with higher melting temperatures than their non-hydroxylated equivalents, because they have a more extended and strengthened intermolecular hydrogen bonding network. Removal of very-long-chain fatty acids from sphingolipids in mutants of the model plant Arabidopsis inhibits completely the development of seedlings. As example of a more specific interaction, it has been demonstrated that synthetic glycerolipids must contain very-long-chain fatty acids (C26) to allow growth in yeast mutants lacking sphingolipids, probably by stabilizing the proton-pumping enzyme H+-ATPase. Similarly, ceramides containing different fatty acids can be used in highly specific ways. Thus in fungi, C16 or C18 hydroxy acids are used exclusively for synthesis of glucosylceramide, while those containing very-long-chain C24 and C26 hydroxy acids are used only for synthesis of glycosyl inositol phosphorylceramide anchors for proteins. In plants, sphingolipids containing 2-hydroxy acids are protective against oxidative and other biotic stresses.

4.  Links between Glycerolipid and Sphingolipid Metabolism

Sphingolipid metabolism and glycerolipid metabolism have been widely treated as separate sciences until relatively recently, partly for historical reasons and partly because the analysis of the two lipid groups required different approaches and skills. However, there are many areas where the two overlap, not least because phosphatidylcholine is the biosynthetic precursor of sphingomyelin in animal cells, while in plants and fungi, phosphatidylinositol is the biosynthetic precursor of ceramide phosphorylinositol. In contrast, ethanolamine phosphate derived from the catabolism of sphingolipids via sphingosine 1-phosphate is recycled for the biosynthesis of phosphatidylethanolamine. In studies in vitro, sphingosine 1-phosphate has been shown to be an activator of the phospholipase C involved in the hydrolysis of phosphatidylinositol 4,5-bisphosphate with formation of diacylglycerols and inositol triphosphate. The location and functions of glycerophospholipids in membranes is influenced both positively and negatively by sphingolipid-rich domains or rafts in membranes.

In addition, there are several examples of phosphoinositides and other complex lipids binding to enzymes of sphingolipid metabolism, either as part of a regulatory function that controls their activity or to facilitate their location to various membranes. Thus, sphingosine kinase 2, one of the enzymes responsible for the biosynthesis of sphingosine 1-phosphate, binds to phosphatidylinositol monophosphates, while the ceramide kinase responsible for the biosynthesis of ceramide 1-phosphate requires phosphatidylinositol 4,5-bisphosphate to function. Similarly, the CERT protein involved in ceramide transport has a binding site for phosphatidylinositol 4-phosphate. Sphingomyelin production at the trans-Golgi network triggers a signalling pathway leading to dephosphorylation of phosphatidylinositol 4-phosphate, interrupting transport of cholesterol and sphingomyelin. Again, the interactions are not solely in one direction as ceramide 1-phosphate (with phosphatidylinositol 4,5-bisphosphate) binds to the specific phospholipase A2 (cPLA2α) responsible for the hydrolysis of phosphatidylinositol and thence the release arachidonic acid for eicosanoid production. Other than the phosphoinositides, phosphatidylserine activates the neutral sphingomyelinase in brain.

The glyceroglycolipid seminolipid from male reproductive tissues and the sphingolipid sulfates have structural elements in common, and they use the same enzymes to introduce the carbohydrate and then the sulfate group to diacylglycerol and ceramide intermediates, respectively. Diacylglycerol acyltransferase 2 (DGAT2), a key enzyme in triacylglycerol biosynthesis, generates 1-O-acylceramides in skin and lipid droplets. It is also noteworthy that the biosynthesis of cholesteryl glycosides in animals involves a transfer of glucose from glucosylceramide to cholesterol by means of cellular β-glucocerebrosidases.

Suggested Reading

Lipid listings Credits/disclaimer Updated: October 11th, 2019 Author: William W. Christie LipidWeb icon